Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

Missed the ISA deadline? Start investing for next year today

You may have missed last year’s ISA deadline but there’s still time to invest this year.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The 2016/17 tax year ended at 12 o’clock last night, which means if you’re putting money aside to save in an ISA, you’ve missed the deadline. 

Luckily, ISA allowances refresh every tax year so while you may have missed last year’s decline, the countdown to the end of the 2017/18 tax year has only just started. 

It’s never too late to start saving and investing. With 12 months now left until the end of this tax year, you’ve got plenty of time to make use of the new, larger ISA allowance. Indeed, for this tax year, the allowance has been increased to £20,000, up from last year’s limit of £15,240. So, if you have money left over you didn’t manage to get into last year’s allowance, there’s plenty of additional room this time round.

Create a long-term plan 

Having a long-term savings plan is key to wealth creation, and a plan is even more important when trying to take advantage of a yearly product such as an ISA. Most people leave contributions to the last minute, which is fraught with risk. What happens if there is a delay in processing your bank transfer? Or what happens if you have to foot the bill for an unexpected, unforeseen expense? If you find yourself rushing to meet the ISA deadline every year, you could be placing unnecessary stress on yourself and your wealth.

And missing out on your ISA allowance can cost thousands. For example, let’s say a higher rate taxpayer invests £10,000 in a share yielding 5%, assuming this investor has already used up their tax-free dividend allowance, the tax on dividend income will be £162.50 per year or £1,625 over 10 years. This might not seem like much in the grand scheme of things, but such missed opportunities add up. What’s more, having to shell out an additional £162.50 per year to the taxman just because of a lack of planning seems like a complete waste of money.

Making the most of the allowance 

Starting a savings plan as early as possible is key to making the most of an ISA allowance. Most providers offer a regular investment plan allowing you to invest in companies such as GlaxoSmithKline (LSE: GSK) on a monthly basis.

Glaxo is the perfect stock for regular ISA investing. As one of the world’s largest pharmaceutical companies the business is highly defensive and Glaxo pays a quarterly dividend to shareholders, which at present works out at an annual rate of 4.8%. The payout is covered around 1.4 times by earnings per share.

Glaxo’s dividend isn’t its only attractive quality. As a pharmaceutical company, its earnings are relatively stable and are set to grow in line with the world’s ever-expanding population. The population is getting older and wealthier, two trends that are advantageous for Glaxo’s earnings as the company can sell more products at higher prices. 

After the firm’s recent restructuring, earnings growth has taken off with earnings per share up 35% last year, and growth of 8% pencilled-in for 2017. The shares currently trade at a forward PE of 14.9, which is not overly expensive for such a defensive high-yield stock.

So overall, now is the time to start investing your ISA allowance for this year and Glaxo could be the perfect place to start. 

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Night Takeoff Of The American Space Shuttle
Investing Articles

4 dirt-cheap growth shares to consider for 2026!

Discover four top growth shares that could take off in the New Year -- and why our writer Royston Wild…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

I asked ChatGPT how to start investing in UK shares with just £500 and it said do this

Harvey Jones asks artificial intelligence a few questions about how to get started in investing, before giving up and deciding…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Dividend Shares

Yielding 10.41%, is this the best dividend share in the FTSE 250?

Jon Smith points out a dividend share with a double-digit yield, but explains why digging below the surface provides important…

Read more »

Investing Articles

Is 2026 the year it all goes wrong for the Rolls-Royce share price?

2025 has been another stellar year for the Rolls-Royce share price but Harvey Jones wonders just how long its magnificent…

Read more »

Night Takeoff Of The American Space Shuttle
Investing Articles

A SpaceX IPO could light a fire under this FTSE 100 stock

Shareholders of this FTSE 100 investment trust may have just got an early Christmas present from Space Exploration Technologies (SpaceX).

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

Can dividends REALLY provide a second income you can live on?

Achieving a strong and sustained passive income in retirement may be easier than you think, even as yields on UK…

Read more »

Market Movers

33p penny stock Made Tech could be set for huge gains in 2026, if City analysts are right

This penny stock just experienced a sharp move higher. However, analysts reckon that there are plenty more gains to come…

Read more »

Elevated view over city of London skyline
Investing Articles

FTSE shares: a simple way to build long-term wealth?

Christopher Ruane explains some factors he thinks an investor should consider when trying to build wealth by investing in FTSE…

Read more »